Skip to main content
C

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,504 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-04 English
VOLUNTARY ANNOUNCEMENT - MARKETING AUTHORISATION APPLICATION FOR AMPHOTERICIN B LIPOSOMAL, POWDER FOR CONCENTRATE FOR DISPERSION FOR INFUSION (HC1507G2) APPROVED IN EUROPE
Regulatory Filings
2026-04-29 English
VOLUNTARY ANNOUNCEMENT - SYS6051 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Regulatory Filings
2026-04-29 English
NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is a notification letter to non-registered shareholders informing them that the Company’s 2025 Annual Report and Circular, Notice of Annual General Meeting and Proxy Form, and the 2025 ESG Report have been published and are available on the Company’s and HKEX websites. It provides instructions for requesting printed copies. It does not contain the full Annual Report, AGM notice, or proxy materials themselves, but merely announces their publication and availability. This fits the definition of a Report Publication Announcement (RPA).
2026-04-28 English
NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is a notification letter informing shareholders of the publication of the 2025 Annual Report and Circular, Notice of Annual General Meeting and Proxy Form, and the 2025 ESG Report on the Company’s website, with instructions on how to request printed copies or change communication preferences. It does not contain the actual report content itself but merely announces its availability. Therefore, it is a Report Publication Announcement (RPA).
2026-04-28 English
LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM
Report Publication Announcement Classification · 1% confidence The document is a shareholder letter regarding the election of means of receipt of the Company’s Corporate Communications and the 2025 ESG Report. It does not contain the full reports themselves, but rather announces the availability of the corporate communications and ESG Report on the company’s and HKEx’s websites and explains how shareholders can request printed copies. This aligns with our definition of a Report Publication Announcement (RPA) – an announcement regarding the release or publication of company reports and details on how to obtain them. It is not the report itself (AGM materials, annual/interim report, ESG report content, etc.), nor a vote solicitation, dividend notice, or other specific category. Thus, it should be classified as RPA.
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.